1394Tip KRYSTAL-7: A Phase III Study of First-Line Adagrasib Plus Pembrolizumab Versus Pembrolizumab Alone in Patients with Advanced NSCLC with KRASG12C Mutation

M.C. Garassino, P.A. Jänne, F. Barlesi,A.I. Spira, T.S.K. Mok,M. Hochmair, K.J. O'Byrne, E. Felip,S-W. Kim, F. Cappuzzo, J. Naidoo, M. Safadi, B. Wamil, J. He, M. Reck

Annals of Oncology（2024）

引用 0|浏览4